Information Library

Results for: Oncology - Central Laboratories

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • ASCO 2012

    Event — Conference Date(s): June 1 - June 5, 2012
    Location: Chicago, IL McCormick Place
    Booth Number: 2062

  • The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

    White Paper — June 23, 2011
    In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance.

  • Genomics Fact Sheet

    Brochure — June 17, 2011
    Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area.

  • Translational R&D Services Fact Sheet

    Brochure — May 26, 2011
    Quintiles’ Translational R&D Center of Excellence performs groundbreaking research and offers novel findings in oncology for biopharmaceutical companies.

  • Quintiles and Population Genetics Technologies Partner

    Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

  • Dr. Frank Massam

    Hear from the Experts — May 13, 2011
    Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd.

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Oncology Expertise - Scientific Collaborator for Global Solutions

    Brochure — January 28, 2011
    Whether you wish to use one of our existing assays, need assistance with developing a new assay, or plan to deploy an assay developed by your diagnostic partner, as your collaborator, Quintiles has the scientific expertise, resources, and flexibility to develop the right solution for you.

  • BIOMODA SELECTS QUINTILES TO HELP DEVELOP MORE ACCURATE AUTOMATED SYSTEM FOR DETECTING EARLY-STAGE LUNG CANCER

    Press Release — November 15, 2010 – Cancer diagnostics company Biomoda, Inc. has allied with Quintiles' Central Laboratories to help refine the automated image recognition system for measuring the photon emission rate and cell morphology of CyPath®-stained cells to detect early stage lung cancer.

  • DAKO AND QUINTILES FORM ALLIANCE TO SPEED DEVELOPMENT OF PERSONALIZED MEDICINE

    Press Release — November 1, 2010 - Dako and Quintiles announced a strategic alliance to advance personalized medicine by collaborating on the co-development of targeted therapies and companion diagnostics.

Page 1 of 3 (26 results)

Subscribe to Email Based on Your Interests

Set preferences